WEE1 and colorectal cancer: The results with enzyme activities were not promising, indicating weak activity at interaction sites with human CK-1δ protein kinase, characteristic targets for treatment in human colorectal cancer cells, in which LASSBio-1920 showed antimitotic activity in this study.